Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Accumulated Expenses (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Accumulated Expenses for 16 consecutive years, with $9.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses fell 13.47% year-over-year to $9.9 million, compared with a TTM value of $9.9 million through Dec 2025, down 13.47%, and an annual FY2025 reading of $9.9 million, down 13.47% over the prior year.
  • Accumulated Expenses was $9.9 million for Q4 2025 at Orthofix Medical, down from $11.4 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $38.8 million in Q4 2023 and bottomed at $9.9 million in Q4 2025.
  • Average Accumulated Expenses over 5 years is $20.4 million, with a median of $18.5 million recorded in 2022.
  • The sharpest move saw Accumulated Expenses soared 109.52% in 2023, then tumbled 70.66% in 2024.
  • Year by year, Accumulated Expenses stood at $23.6 million in 2021, then decreased by 21.32% to $18.5 million in 2022, then skyrocketed by 109.52% to $38.8 million in 2023, then crashed by 70.66% to $11.4 million in 2024, then dropped by 13.47% to $9.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for OFIX at $9.9 million in Q4 2025, $11.4 million in Q4 2024, and $38.8 million in Q4 2023.